VMD
Get informed when a big investor buys or sells
+ FollowOvervalued by 32.2% based on the discounted cash flow analysis.
| Market cap | $471.93 Million |
|---|---|
| Enterprise Value | $483.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.38 |
| Beta | 1.1 |
| Outstanding Shares | 38,428,588 |
| P/E Ratio | 31.8 |
|---|---|
| PEG | -1941.31 |
| Price to Sales | 1.71 |
| Price to Book Ratio | 3.98 |
| Enterprise Value to Revenue | 1.69 |
| Enterprise Value to EBIT | 20.86 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.15 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.04%▼ 63.88% |
|---|---|
| Total Invested | $166,405▼ 99.93% |
| Investors Holding | 4▼ 145.00% |
No data
Viemed Healthcare Inc. is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed's service offerings are focused on effective in-home treatment with clinical practitioners prov...